Oramed Pharma (ORMP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 11-2021 | 09-2021 | 08-2021 | |
| Sales | 666 | -1,124 | 674 | 682 | 0 |
| Gross Profit | 666 | -1,126 | 674 | 682 | N/A |
| Operating Expenses | 11,918 | -7,331 | 8,734 | 8,167 | 0 |
| Operating Income | -11,252 | 6,145 | -8,060 | -7,485 | N/A |
| Interest Expense | 0 | 354 | 175 | 51 | 0 |
| Other Income | 544 | -277 | 137 | 0 | 0 |
| Pre-tax Income | -10,708 | 5,514 | -8,098 | -7,536 | 0 |
| Net Income Continuous | -10,708 | 5,253 | -8,098 | -7,536 | N/A |
| Minority Interests | N/A | 318 | -208 | -279 | N/A |
| Net Income | $-10,708 | $5,076 | $-7,890 | $-7,257 | $N/A |
| EPS Basic Total Ops | -0.27 | 0.24 | -0.22 | -0.21 | N/A |
| EPS Basic Continuous Ops | -0.28 | 0.23 | -0.22 | -0.22 | N/A |
| EPS Diluted Total Ops | -0.27 | 0.24 | -0.22 | -0.21 | N/A |
| EPS Diluted Continuous Ops | -0.28 | 0.23 | -0.22 | -0.22 | N/A |
| EBITDA(a) | $-11,241 | $6,215 | $-8,048 | $-7,474 | $N/A |